Buffett’s $9.7B OxyChem acquisition — why investing experts say it’s genius

MSN
2026.01.17 14:38

Lean how Berkshire Hathaway’s $9.7B OxyChem acquisition boosts cash flow, strengthens Occidental and reflects Warren Buffett’s value investing strategy.